Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

XPeng (XPEV.N)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (US$)	Price Target (US$)	Rating
2022-02-25	35.03	48.00	Neutral
2022-04-04	31.40	34.00	Neutral
2022-11-17	8.00	13.00	Buy
2023-03-17	8.84	12.00	Buy
2023-07-30	23.39	-	No Rating
2023-07-31	20.92	23.00	Neutral
2023-11-01	15.50	15.00	Neutral
2024-03-27	7.81	8.30	Neutral
2024-08-20	6.77	8.20	Neutral
2024-12-05	12.54	8.80	Sell
2025-02-23	18.40	18.00	Neutral

Disclosures

UBS Securities Hong Kong Limited is a market maker in the Hong Kong-listed securities of this company.
UBS Securities LLC makes a market in the securities and/or ADRs of this company.
Because this security exhibits higher-than-average volatility, the FSR has been set at 15% above the MRA for a Buy rating, and at -15% below the MRA for a Sell rating (compared with 6/-6% under the normal rating system).
UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.